These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

604 related articles for article (PubMed ID: 28860764)

  • 1. Liposomal curcumin and its application in cancer.
    Feng T; Wei Y; Lee RJ; Zhao L
    Int J Nanomedicine; 2017; 12():6027-6044. PubMed ID: 28860764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in nanotechnology-based delivery systems for curcumin.
    Sun M; Su X; Ding B; He X; Liu X; Yu A; Lou H; Zhai G
    Nanomedicine (Lond); 2012 Jul; 7(7):1085-100. PubMed ID: 22846093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Robust Microfluidic Technology and New Lipid Composition for Fabrication of Curcumin-Loaded Liposomes: Effect on the Anticancer Activity and Safety of Cisplatin.
    Hamano N; Böttger R; Lee SE; Yang Y; Kulkarni JA; Ip S; Cullis PR; Li SD
    Mol Pharm; 2019 Sep; 16(9):3957-3967. PubMed ID: 31381352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and in-vitro/in-vivo evaluation of curcumin nanosuspension with solubility enhancement.
    Li X; Yuan H; Zhang C; Chen W; Cheng W; Chen X; Ye X
    J Pharm Pharmacol; 2016 Aug; 68(8):980-8. PubMed ID: 27283220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent progress in studying curcumin and its nano-preparations for cancer therapy.
    Liu J; Chen S; Lv L; Song L; Guo S; Huang S
    Curr Pharm Des; 2013; 19(11):1974-93. PubMed ID: 23116308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery of curcumin by directed self-assembled micelles enhances therapeutic treatment of non-small-cell lung cancer.
    Zhu WT; Liu SY; Wu L; Xu HL; Wang J; Ni GX; Zeng QB
    Int J Nanomedicine; 2017; 12():2621-2634. PubMed ID: 28435247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin nanoformulations: Beneficial nanomedicine against cancer.
    Maleki Dizaj S; Alipour M; Dalir Abdolahinia E; Ahmadian E; Eftekhari A; Forouhandeh H; Rahbar Saadat Y; Sharifi S; Zununi Vahed S
    Phytother Res; 2022 Mar; 36(3):1156-1181. PubMed ID: 35129230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The suitability of liposomes for the delivery of hydrophobic drugs - A case study with curcumin.
    Kolter M; Wittmann M; Köll-Weber M; Süss R
    Eur J Pharm Biopharm; 2019 Jul; 140():20-28. PubMed ID: 31015019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conundrum and therapeutic potential of curcumin in drug delivery.
    Kumar A; Ahuja A; Ali J; Baboota S
    Crit Rev Ther Drug Carrier Syst; 2010; 27(4):279-312. PubMed ID: 20932240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in lipo-solubility delivery vehicles for curcumin: bioavailability, precise targeting, possibilities and challenges.
    Wen C; Cao L; Yu Z; Liu G; Zhang J; Xu X
    Crit Rev Food Sci Nutr; 2024; 64(29):10835-10854. PubMed ID: 37410019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanotechnology-applied curcumin for different diseases therapy.
    Ghalandarlaki N; Alizadeh AM; Ashkani-Esfahani S
    Biomed Res Int; 2014; 2014():394264. PubMed ID: 24995293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress in nanotechnology-based drug carrier in designing of curcumin nanomedicines for cancer therapy: current state-of-the-art.
    Ahmad MZ; Alkahtani SA; Akhter S; Ahmad FJ; Ahmad J; Akhtar MS; Mohsin N; Abdel-Wahab BA
    J Drug Target; 2016; 24(4):273-93. PubMed ID: 26066739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High drug payload curcumin nanosuspensions stabilized by mPEG-DSPE and SPC: in vitro and in vivo evaluation.
    Hong J; Liu Y; Xiao Y; Yang X; Su W; Zhang M; Liao Y; Kuang H; Wang X
    Drug Deliv; 2017 Nov; 24(1):109-120. PubMed ID: 28155567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospects of Curcumin Nanoformulations in Cancer Management.
    Amekyeh H; Alkhader E; Sabra R; Billa N
    Molecules; 2022 Jan; 27(2):. PubMed ID: 35056675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmaceutical strategies of improving oral systemic bioavailability of curcumin for clinical application.
    Ma Z; Wang N; He H; Tang X
    J Control Release; 2019 Dec; 316():359-380. PubMed ID: 31682912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silica-coated flexible liposomes as a nanohybrid delivery system for enhanced oral bioavailability of curcumin.
    Li C; Zhang Y; Su T; Feng L; Long Y; Chen Z
    Int J Nanomedicine; 2012; 7():5995-6002. PubMed ID: 23233804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor Targeted Curcumin Delivery by Folate-Modified MPEG-PCL Self-Assembly Micelles for Colorectal Cancer Therapy.
    Hu Y; He Y; Ji J; Zheng S; Cheng Y
    Int J Nanomedicine; 2020; 15():1239-1252. PubMed ID: 32110020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The bioavailability, metabolism and microbial modulation of curcumin-loaded nanodelivery systems.
    Chang R; Chen L; Qamar M; Wen Y; Li L; Zhang J; Li X; Assadpour E; Esatbeyoglu T; Kharazmi MS; Li Y; Jafari SM
    Adv Colloid Interface Sci; 2023 Aug; 318():102933. PubMed ID: 37301064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity.
    Kim TH; Jiang HH; Youn YS; Park CW; Tak KK; Lee S; Kim H; Jon S; Chen X; Lee KC
    Int J Pharm; 2011 Jan; 403(1-2):285-91. PubMed ID: 21035530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral bioavailability of curcumin: problems and advancements.
    Liu W; Zhai Y; Heng X; Che FY; Chen W; Sun D; Zhai G
    J Drug Target; 2016 Sep; 24(8):694-702. PubMed ID: 26942997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.